Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 29298 | 27.18 |
09:34 ET | 4814 | 27.13 |
09:36 ET | 5344 | 27.135 |
09:38 ET | 3856 | 27.15 |
09:39 ET | 2117 | 27.14 |
09:41 ET | 2500 | 27.165 |
09:43 ET | 16436 | 27.27 |
09:45 ET | 11952 | 27.28 |
09:48 ET | 3903 | 27.29 |
09:50 ET | 4241 | 27.35 |
09:52 ET | 3240 | 27.345 |
09:54 ET | 6075 | 27.325 |
09:56 ET | 2307 | 27.335 |
09:57 ET | 4870 | 27.4 |
09:59 ET | 14109 | 27.345 |
10:01 ET | 2867 | 27.36 |
10:03 ET | 10377 | 27.4 |
10:06 ET | 14215 | 27.44 |
10:08 ET | 8260 | 27.43 |
10:10 ET | 4695 | 27.425 |
10:12 ET | 2381 | 27.43 |
10:14 ET | 4247 | 27.45 |
10:15 ET | 1935 | 27.475 |
10:17 ET | 9949 | 27.45 |
10:19 ET | 2200 | 27.45 |
10:21 ET | 6642 | 27.44 |
10:24 ET | 2741 | 27.445 |
10:26 ET | 6505 | 27.445 |
10:28 ET | 6423 | 27.455 |
10:30 ET | 6809 | 27.485 |
10:32 ET | 5985 | 27.455 |
10:33 ET | 1925 | 27.465 |
10:35 ET | 4202 | 27.465 |
10:37 ET | 3892 | 27.485 |
10:39 ET | 1625 | 27.47 |
10:42 ET | 3396 | 27.495 |
10:44 ET | 382 | 27.495 |
10:46 ET | 600 | 27.49 |
10:48 ET | 2600 | 27.495 |
10:50 ET | 12405 | 27.46 |
10:51 ET | 6426 | 27.45 |
10:53 ET | 3933 | 27.445 |
10:55 ET | 7533 | 27.465 |
10:57 ET | 1077 | 27.465 |
11:00 ET | 7829 | 27.46 |
11:02 ET | 32475 | 27.505 |
11:04 ET | 600 | 27.5 |
11:06 ET | 3242 | 27.515 |
11:08 ET | 5754 | 27.55 |
11:09 ET | 2300 | 27.5 |
11:11 ET | 3605 | 27.52 |
11:13 ET | 5145 | 27.525 |
11:15 ET | 14171 | 27.495 |
11:18 ET | 20555 | 27.52 |
11:20 ET | 2612 | 27.49 |
11:22 ET | 27185 | 27.48 |
11:24 ET | 11039 | 27.47 |
11:26 ET | 2865 | 27.4899 |
11:27 ET | 4997 | 27.45 |
11:29 ET | 4500 | 27.48 |
11:31 ET | 2900 | 27.4625 |
11:33 ET | 6709 | 27.465 |
11:36 ET | 3860 | 27.5 |
11:38 ET | 2461 | 27.51 |
11:40 ET | 4200 | 27.5 |
11:42 ET | 3561 | 27.51 |
11:44 ET | 700 | 27.49 |
11:45 ET | 1300 | 27.495 |
11:47 ET | 1189 | 27.49 |
11:49 ET | 4800 | 27.505 |
11:51 ET | 3637 | 27.495 |
11:54 ET | 100 | 27.495 |
11:56 ET | 5379 | 27.445 |
11:58 ET | 4296 | 27.45 |
12:00 ET | 1025 | 27.445 |
12:02 ET | 2646 | 27.455 |
12:03 ET | 1163 | 27.455 |
12:05 ET | 2547 | 27.445 |
12:07 ET | 2089 | 27.45 |
12:09 ET | 3125 | 27.44 |
12:12 ET | 2044 | 27.45 |
12:14 ET | 700 | 27.465 |
12:16 ET | 570 | 27.46 |
12:18 ET | 700 | 27.46 |
12:20 ET | 2889 | 27.465 |
12:21 ET | 3629 | 27.48 |
12:23 ET | 3652 | 27.485 |
12:25 ET | 2925 | 27.465 |
12:27 ET | 3126 | 27.47 |
12:30 ET | 4418 | 27.485 |
12:32 ET | 4159 | 27.48 |
12:34 ET | 1613 | 27.475 |
12:36 ET | 1905 | 27.475 |
12:38 ET | 3000 | 27.48 |
12:39 ET | 1676 | 27.48 |
12:41 ET | 1076 | 27.47 |
12:43 ET | 500 | 27.475 |
12:45 ET | 3511 | 27.48 |
12:48 ET | 300 | 27.475 |
12:50 ET | 1600 | 27.485 |
12:52 ET | 1685 | 27.485 |
12:54 ET | 4863 | 27.53 |
12:56 ET | 4396 | 27.515 |
12:57 ET | 2541 | 27.52 |
12:59 ET | 1300 | 27.505 |
01:01 ET | 751 | 27.505 |
01:03 ET | 4280 | 27.495 |
01:06 ET | 3350 | 27.5164 |
01:08 ET | 1393 | 27.5101 |
01:10 ET | 2146 | 27.53 |
01:12 ET | 1062 | 27.5439 |
01:14 ET | 2541 | 27.54 |
01:15 ET | 2420 | 27.5401 |
01:17 ET | 4532 | 27.545 |
01:19 ET | 9463 | 27.52 |
01:21 ET | 6723 | 27.525 |
01:24 ET | 8632 | 27.52 |
01:26 ET | 1602 | 27.505 |
01:28 ET | 1480 | 27.5 |
01:30 ET | 6583 | 27.465 |
01:32 ET | 7208 | 27.41 |
01:33 ET | 1403 | 27.4 |
01:35 ET | 7600 | 27.36 |
01:37 ET | 2360 | 27.36 |
01:39 ET | 3341 | 27.345 |
01:42 ET | 12640 | 27.38 |
01:44 ET | 11278 | 27.415 |
01:46 ET | 3684 | 27.405 |
01:48 ET | 6041 | 27.38 |
01:50 ET | 4569 | 27.405 |
01:51 ET | 1654 | 27.405 |
01:53 ET | 600 | 27.405 |
01:55 ET | 2242 | 27.41 |
01:57 ET | 1539 | 27.42 |
02:00 ET | 2462 | 27.43 |
02:02 ET | 3069 | 27.415 |
02:04 ET | 16136 | 27.4 |
02:06 ET | 1019 | 27.415 |
02:08 ET | 1576 | 27.415 |
02:09 ET | 3347 | 27.415 |
02:11 ET | 2484 | 27.41 |
02:13 ET | 2037 | 27.415 |
02:15 ET | 2141 | 27.405 |
02:18 ET | 5290 | 27.4 |
02:20 ET | 14263 | 27.42 |
02:22 ET | 6116 | 27.41 |
02:24 ET | 6577 | 27.395 |
02:26 ET | 3890 | 27.385 |
02:27 ET | 4716 | 27.38 |
02:29 ET | 4955 | 27.365 |
02:31 ET | 2400 | 27.3875 |
02:33 ET | 5460 | 27.365 |
02:36 ET | 1896 | 27.36 |
02:38 ET | 2356 | 27.35 |
02:40 ET | 5354 | 27.35 |
02:42 ET | 1158 | 27.355 |
02:44 ET | 3055 | 27.355 |
02:45 ET | 12202 | 27.35 |
02:47 ET | 2992 | 27.36 |
02:49 ET | 1200 | 27.365 |
02:51 ET | 5785 | 27.38 |
02:54 ET | 3022 | 27.385 |
02:56 ET | 969 | 27.385 |
02:58 ET | 5720 | 27.395 |
03:00 ET | 3024 | 27.4 |
03:02 ET | 500 | 27.405 |
03:03 ET | 6529 | 27.415 |
03:05 ET | 7958 | 27.415 |
03:07 ET | 12972 | 27.39 |
03:09 ET | 1450 | 27.395 |
03:12 ET | 6494 | 27.395 |
03:14 ET | 4835 | 27.385 |
03:16 ET | 5223 | 27.38 |
03:18 ET | 9565 | 27.39 |
03:20 ET | 3868 | 27.355 |
03:21 ET | 6114 | 27.355 |
03:23 ET | 3011 | 27.37 |
03:25 ET | 1596 | 27.365 |
03:27 ET | 11407 | 27.365 |
03:30 ET | 7480 | 27.355 |
03:32 ET | 9604 | 27.37 |
03:34 ET | 15529 | 27.365 |
03:36 ET | 5677 | 27.375 |
03:38 ET | 13417 | 27.395 |
03:39 ET | 6404 | 27.395 |
03:41 ET | 12923 | 27.37 |
03:43 ET | 14045 | 27.365 |
03:45 ET | 7883 | 27.37 |
03:48 ET | 11217 | 27.36 |
03:50 ET | 14319 | 27.355 |
03:52 ET | 27423 | 27.385 |
03:54 ET | 24602 | 27.365 |
03:56 ET | 49504 | 27.365 |
03:57 ET | 56155 | 27.35 |
03:59 ET | 150725 | 27.33 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 16.3B | 15.3x | +1.83% |
Amneal Pharmaceuticals Inc | 2.1B | -11.8x | --- |
Catalent Inc | 9.9B | -8.5x | --- |
Jazz Pharmaceuticals PLC | 6.7B | 21.8x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Roivant Sciences Ltd | 9.1B | 2.2x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.3B |
---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.07% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.46 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 15.3x |
Price/Sales (TTM) | 7.3 |
Price/Cash Flow (TTM) | 13.7x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.